|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
Favrille, Inc.
|
|
|
Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
|
| 2. |
Arqule, Inc.
|
|
|
Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)
|
| 3. |
Genaera Corp.
|
|
|
Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)
|
| 4. |
ImmunoGen, Inc.
|
|
|
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
|
| 5. |
Heal Corporation
|
|
|
Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
